Security key
55083R104
Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (LYEL)
CUSIP: 55083R104
Q1 2022 13F Holders as of 31 Mar 2022
- Security type / class
- Equity / Common Stock par value $0.0001 per share
- Total 13F shares
- 99,521,989
- Total 13F value
- $502,714,970
- Share change
- +13,959,163
- Put/Call ratio
- 2%
- SEC-reported price per share
- $5.05
- Number of holders
- 78
- Value change
- +$55,442,935
- Number of buys
- 51
- Number of sells
- 25
- Shares outstanding
- 23,360,878
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2022
Institutions
78
Top holders
10
LYEL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Lyell Immunopharma, Inc. SEC filings
Lyell Immunopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 55083R104
Recent filing periods:
Ownership snapshot
Top reported holders of LYEL - Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MWG Management Ltd.
Disclosed value leader
MWG Management Ltd.
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F
Lead comparable stake: 86%
Showing 1-6 of 15 holder rows.
Quick read
MWG Management Ltd. leads the comparable SEC ownership view at 86%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MWG Management Ltd.'s linked filing trail.
Comparable ownership
Top 5
MWG Management Ltd.
86%
Apoletto Ltd
65%
Foresite Capital Management IV, LLC
57%
Alphabet Inc.
25%
PRICE T ROWE ASSOCIATES INC /MD/
22%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MWG Management Ltd. |
13F
Company
|
86%
|
$156,056,000
20,162,332 shares
|
— | 31 Dec 2021 |
| Apoletto Ltd |
13F
Company
|
65%
|
$116,827,000
15,093,969 shares
|
— | 31 Dec 2021 |
| Foresite Capital Management IV, LLC |
13F
Company
|
57%
|
$102,804,000
13,282,181 shares
|
— | 31 Dec 2021 |
| Alphabet Inc. |
13F
Company
|
25%
|
$45,396,000
5,865,125 shares
|
— | 31 Dec 2021 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
22%
|
$39,794,000
5,141,291 shares
|
— | 31 Dec 2021 |
| SB Management Ltd |
13F
Company
|
15%
|
$27,090,000
3,500,000 shares
|
— | 31 Dec 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
99,521,989
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
76
Q1 2022 holders
78
Holder diff
2
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 value | Q1 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend